Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Bruce J. Kinon |
Documentos disponibles escritos por este autor (3)
Refinar búsquedaEffectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation / Robert W. Baker en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)
Título : Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation Tipo de documento: texto impreso Autores: Robert W. Baker, Autor ; Bruce J. Kinon, Autor ; Gerald Maguire, Autor Fecha de publicación: 2023 Artículo en la página: pp. 342-348 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Agitación psicomotora. Resumen: Patients experiencing an acute decompensation of schizophrenia or bipolar disorder often present in an agitated state. Agitation presents a barrier to therapy, interrupting the typical physician-patient alliance and creating a disruptive, even hazardous, environment. Rapid assessment and effective treatment are necessary to manage agitation and, potentially, to shorten the time to recovery. Link: ./index.php?lvl=notice_display&id=31008
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 342-348[artículo] Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation [texto impreso] / Robert W. Baker, Autor ; Bruce J. Kinon, Autor ; Gerald Maguire, Autor . - 2023 . - pp. 342-348.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 342-348
Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Agitación psicomotora. Resumen: Patients experiencing an acute decompensation of schizophrenia or bipolar disorder often present in an agitated state. Agitation presents a barrier to therapy, interrupting the typical physician-patient alliance and creating a disruptive, even hazardous, environment. Rapid assessment and effective treatment are necessary to manage agitation and, potentially, to shorten the time to recovery. Link: ./index.php?lvl=notice_display&id=31008
Título : Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia Tipo de documento: texto impreso Autores: Bruce J. Kinon, Autor ; Virginia L. Stauffer, Autor Fecha de publicación: 2023 Artículo en la página: pp. 601-607 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad aguda, Agentes antipsicóticos, Benzodiazepinas, Glucosa en sangre/efectos por medicamentos, Hospitalización, Lorazepam, Olanzapina, Piperazinas, Agitación psicomotora, Agitación psicomotora, Esquizofrenia. Resumen: Rapid control of agitation is of critical importance in the treatment of acutely ill patients with schizophrenia. Both olanzapine and aripiprazole have been shown to be safe and effective in this setting, with each having somewhat different receptor binding affinity profiles. Link: ./index.php?lvl=notice_display&id=30817
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 601-607[artículo] Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia [texto impreso] / Bruce J. Kinon, Autor ; Virginia L. Stauffer, Autor . - 2023 . - pp. 601-607.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 601-607
Palabras clave: Enfermedad aguda, Agentes antipsicóticos, Benzodiazepinas, Glucosa en sangre/efectos por medicamentos, Hospitalización, Lorazepam, Olanzapina, Piperazinas, Agitación psicomotora, Agitación psicomotora, Esquizofrenia. Resumen: Rapid control of agitation is of critical importance in the treatment of acutely ill patients with schizophrenia. Both olanzapine and aripiprazole have been shown to be safe and effective in this setting, with each having somewhat different receptor binding affinity profiles. Link: ./index.php?lvl=notice_display&id=30817
Título : Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder : A randomized, double-blind, fixed-dose study Tipo de documento: texto impreso Autores: Bruce J. Kinon, Autor ; Jan Volavka, Autor ; Virginia L. Stauffer, Autor Fecha de publicación: 2023 Artículo en la página: pp. 392-400 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Relación Dosis-Respuesta, Olanzapina, Prolactina, Trastornos psicóticos, Esquizofrenia. Resumen: The objective of this study was to assess the dose-response relationship of standard and higher doses of olanzapine in a randomized, double-blind, 8-week, fixed-dose study comparing olanzapine 10 (n = 199), 20 (n = 200), and 40 mg/d (n = 200) for patients with schizophrenia or schizoaffective disorder and suboptimal response to current treatment. Patients meeting criteria for antipsychotic treatment resistance were excluded. Link: ./index.php?lvl=notice_display&id=30838
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 392-400[artículo] Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder : A randomized, double-blind, fixed-dose study [texto impreso] / Bruce J. Kinon, Autor ; Jan Volavka, Autor ; Virginia L. Stauffer, Autor . - 2023 . - pp. 392-400.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 392-400
Palabras clave: Antipsicóticos, Benzodiazepinas, Relación Dosis-Respuesta, Olanzapina, Prolactina, Trastornos psicóticos, Esquizofrenia. Resumen: The objective of this study was to assess the dose-response relationship of standard and higher doses of olanzapine in a randomized, double-blind, 8-week, fixed-dose study comparing olanzapine 10 (n = 199), 20 (n = 200), and 40 mg/d (n = 200) for patients with schizophrenia or schizoaffective disorder and suboptimal response to current treatment. Patients meeting criteria for antipsychotic treatment resistance were excluded. Link: ./index.php?lvl=notice_display&id=30838
